28 Vivani Medical Shares Surge On Non-Clinical Results Release

Shares Jump As Vivani medical Announces Non-Clinical Weight Loss Effect On NPM-115 And Others.

The company announced positive clinical data on the weight loss effects of NPM-115 – the company’s small exenatide implant it is developing for chronic weight management treatment, according to Reuters and Marketwatch etc.

Go to Marketwatch and watch itNPM-115 (Enatide Implant) exhibited weight loss comparable to that of semaglutide (Ozempic®/Wegovy), which is administered twice a year.

What is NPM-115

NPM-115 is a small subcutaneous implant designed to ensure drug compliance and potentially improve treatment tolerability

Vivani Medical is an innovative preclinical biopharmaceutical company developing long-term new drug implants.

in addition to

Bottlebreaker is offering a variety of interesting news. You can get in touch faster by writing down your email address below.

who is elon musk